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Abstract  
Introduction The inflammatory process of head and neck cancer leads to increased 
proinflammatory cytokines and the synthesis of c-reactive protein (CRP), which then cause 
metabolic alteration and anorexia in patients. Zinc is one of nutrients that has an important role in 
suppressing inflammation, however it is reported that around 65% of head and neck cancer patients 
had zinc deficiency. The aim of this cross sectional study is to determine the correlation between 
zinc intake and serum zinc levels with CRP level as an effort in reducing inflammation process in 
head and neck cancer patients.  
Methods and Results Subjects were collected by using consecutive sampling in the Oncology Clinic 
Dharmais Cancer Hospital. From 49 subjects, 67.3% were men, most subjects were in the age range 
between 46–65 years old. The most common (65.3%) was nasopharyngeal cancer and 69.4% were 
already in stage IV. All subjects (100%) in this study had zinc intake below the recommended dietary 
allowance (RDA) in Indonesia. The mean serum zinc level of the subjects was 9.83±2.62 μmol/L. 
Most subjects have elevated CRP levels. There was a weak negative correlation between zinc levels 
and CRP levels (r =-0.292, p =0.042), however there was no correlation between zinc intake and CRP 
levels of subjects (r =-0.25).  
Conclusion There was negative correlation between serum zinc level and CRP levels in the subjects. 
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Introduction 
 
Head and neck cancer is the seventh most common 
malignant disease in the world, where the number of 
new cases each year is increasing and causing many 
deaths.1–3 The inflammatory process in cancer leads 
to increased proinflammatory cytokines such as 
interleukin (IL)-1, IL-6, tumor necrosis factor-alpha 
(TNF-α) and interferon-γ (IFN-γ).4,5 The increase of 
proinflammatory cytokines will cause metabolic 
alteration, loss in appetite, induce satiety, resulting 
in anorexia and weight loss in cancer patients.6 As 
response to the inflammatory process, the body will 
increase acute phase proteins synthesis in the liver 
as a defense mechanism.6 C-reactive protein (CRP) 
is one of the acute phase proteins that are sensitive 
to acute inflammation, infections, and tissue 
damage.7 
Zinc is a nutrient that plays an important role 
in suppressing inflammation, however it is reported 
that about 65% of head and neck cancer patients 
have zinc deficiency.8 Zinc deficiency in head and 
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neck cancer patients is thought to be due to low zinc 
intake, low bioavailability, high molar ratio of 
phytate to zinc in food, and increased amount of 
reactive oxygen species (ROS).9–11 Zinc deficiency 
in cancer patients results in decreased appetite and 
dietary intake, taste and smell disorder, immune 
system dysfunction, and increased risk of 
complications.8,12  Zinc deficiency also affects the 
formation of cytokines, especially IL-1β, IL-2. IL-6, 
and TNF-α. The interaction between zinc and 
inflammatory cytokines is interrelated. Cytokines 
can increase and decrease the regulation of cellular 
zinc transporter expression in response to an 
increased need for zinc in inflammatory 
conditions.13 However, zinc also has the ability to 
decrease the production of inflammatory cytokines 
through the up regulation of zinc finger protein (A20 
protein) which inhibit the activation of NF-κB 
(nuclear factor kappa B), the major transcription 
factor in inflammation.13,14 
 The aim of this study is to determine the 
correlation between zinc intake and serum zinc 
levels with CRP levels in head neck cancer patients 
as an effort to reduce inflammation and, therefore, 
reduce anorexia. 
 
Methods 
 
Subjects and Study Design 
This cross sectional study conducted in Oncology 
Clinic of Dharmais Cancer Hospital, Jakarta. 
Sample size was determined based on the correlation 
analysis (α = 0.05; β = 0.20; r = 0.4), with estimated 
10% of drop out, the sum of samples was 52 
subjects. However, the subjects who completed the 
research were 49 subjects. Inclusion criteria were: 
patients at the Oncology Clinic of Dharmais Cancer 
Hospital who were diagnosed with head and neck 
cancer, stage I-IV, age above 18 years, had not 
received surgical therapy, radiation, or 
chemotherapy, willing to participate by signing the 
informed consent. Exclusion criteria were: had acute 
or chronic infections, had diarrhea, impaired liver 
and kidney function. 
 
Data Collection   
Data collection was conducted in September 2016 
until December 2016 after obtaining approval from 
the Health Research Ethics Committee of Dharmais 
Cancer Hospital Number 054 / KEPK / IX / 2016. 
Subject characteristics including age and sex were 
collected by interview. Assessment of zinc intake 
was done by using semi-quantitative FFQ, which 
was then processed using Nutrisurvey 2007. 
Anthropometric measurements were performed to 
obtain data of height and weight. Heights were 
measured using Microtoise Stature Meter 200 cm 
(with 0.1 cm accuracy). Weight measurement was 
done by using Seca electro digital scale 876, 
Germany. Both anthropometric measurements were 
performed twice and the average results will be 
used. Nutritional status assessment were based on 
body mass index. Type and stage of cancer were 
obtained from medical records. Three mL of blood 
samples were taken from the cubital vein, which 
were then centrifuged at 3000 rpm to obtain the 
serum. Atomic absorption spectrophotometry 
method was used for the serum zinc examination 
using 1 ml of serum which has been transferred to 
the acid-washed serum cup. Whereas examination of 
CRP levels used immunoturbidimetry method of 
COBAS 501. 
 
Statistical Analysis 
Data were analyzed by using SPSS version 20.0. 
Normality test was done by using Kolmogorov 
Smirnov. Spearman correlation test was used to 
determine correlation between zinc intake with CRP 
levels and serum zinc levels with CRP levels. 
 
Results 
 
A total of 49 subjects participated in this study. Most 
subjects (67.3%) were male, the mean age was 
48.33±12.73 years old and most of them (53.1%) 
were in the age range 46-65 years. Characteristic 
subjects based on age, gender, type of cancer, stage 
of cancer, status and nutritional intake, serum zinc 
levels, and CRP levels are shown in Table 1. Types 
of cancer consist of nasopharyngeal cancer, larynx, 
tonsil, sinonasal, and tongue. Nasopharyngeal 
cancer was the most common (32 people (65.3%)). 
Most subjects (69.4%) were in stage IV. Mean of 
body mass index was 22.20±4.2 kg/m2: 42.9% 
subjects were overweight, 32.7% were 
normoweight, and 24.5% were underweight. 
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The mean zinc serum levels were 9.3±2.62 µmol/L Table 1. Characteristics of the subjects 
Characteristics Frequency 
47 (%) 
Mean±SD or 
Median (min–max) 
Age(year)  48.33±12.73 
18 – 25 1 (2)  
26 – 45 19 (38.8)  
46 – 65 26 (53.1)  
>65 3 (6.1)  
Gender   
Male 33 (67.3)  
Female 16 (32.7)  
Type of cancer   
Nasopharynx 32 (65.3)  
Larynx 5 (10.2)  
Sinonasal 4 (8.2)  
Tonsils 4 (8.2)  
Tongue 3 (6.1)  
Stage of cancer   
I 1 (2.0)  
II 7 (14.3)  
III 7 (14.3)  
IV 34 (69.4)  
Body mass index  (kg/m2)  22.20±4.52 
Underweight 12 (24.5)  
Normoweight 16 (32.7)  
Overweight 21 (42.9)  
Energy intake  1434.07±558.02 
Adequate (≥30 kcal/kg BW/day) 15 (30.6)  
Inadequate (<30 kcal/kg BWday) 34 (69.4)  
Protein intake  46.66±22.96 
Adequate (≥1 g/kgBW/day) 16 (32.7)  
Inadequate (<1 g/kgBW/day) 33 (67.3)  
Zinc intake  
Adequate ( ≥13 mg/day) 
Inadequate (<13 mg/day) 
 
 
 
0 (0) 
47 (100) 
 
3.70 (1.20-11.70) 
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The mean zinc serum levels were 9.3±2.62 µmol/L 
and more than half the subjects (59.2%) has low 
serum zinc level. The median CRP serum of the 
subjects was at 6.03 (0.33 to 339.29) mg/L and most 
(51.0%) subjects had levels greater than 5 mg/L 
(data are shown in Table 2). 
 
Table 2. Zinc serum and CRP levels of the subjects 
 
Variable Frequency 
n (%) 
Mean±SD or 
Median (min–max) 
Zinc serum 
(µmol/L) 
 9.83±2.62 
Adequate  20 (40.8)  
Deficiency 29 (59.2)  
CRP serum 
(mg/L) 
 6.03 (0.33–339.29) 
Adequate 24 (49.0)  
High 25 (51.0)  
 
This study found a negative weak correlation 
between serum zinc levels and CRP levels (r = -
0.292, p =0.042), but no correlation between zinc 
intake and CRP levels (r= -0.25, p =0.86). Data are 
summarized in Table 3. 
 
Table 3. Correlation between zinc intake with CRP levels 
and zinc serum levels with CRP levels 
 
Variable CRP serum (mg/L)  
 r P 
Zinc intake (mg/day) 
Zinc serum (µmol/L) 
-0.25 
-0.292 
0.86 
0.042 
 
Discussion 
 
Dietary zinc intake of all subjects in this study did 
not meet the Indonesian RDA (13 mg/day for male 
and 10 mg/day for female).12 The lowest and highest 
intake of zinc in male subjects were 1.5 mg/day and 
11.7 mg/day, while in female subjects the lowest 
zinc intake was 1.2 mg/day and the highest was 6.3 
mg/day. Similar results were obtained by Westin et 
al13 who found the zinc intake in cancer subjects for 
two days food record was 9±2 mg/day. A cross 
sectional study by Irene et al3 in the 2011 found that 
most of the subjects (80.6%) were included in the 
inadequate zinc intake group. The lack of zinc intake 
in this study is thought to be due to various factors 
including the presence of intake disorders due to 
tumor sites in the aerodigestive tract and pain that 
causes the anorexia. Most of the subjects in this 
study deliberately reduced the portion of food and 
avoid eating red meat, offal, eggs, milk, and animal-
derived food, albeit high protein food are the main 
source of zinc in the diet. Therefore, the increase of 
zinc intake depends on increasing protein intake. 
 The mean serum zinc level in this study 
was 9.83±2.62 μmol/L and 52% of subjects were in 
the low serum zinc group. This is similar to study by 
Irene et al3 which found serum zinc level median of 
7.42 (4.16-14.67) μmol/L and 88.89% of the 
subjects had low serum zinc level. Sattar et al14 also 
revealed that zinc concentrations in lung cancer 
patients were lower than controls. Based on the 
theory, low zinc levels in cancer patients can be 
caused by low intake, inflammatory state, the 
influence of proinflammatory cytokines, and 
increased number of ROS.3–5,8,11 In this study most 
of the stage IV subjects (61.8%) had low serum zinc 
levels. This low serum zinc level is thought to be 
associated with low total zinc intake of subjects and 
the redistribution to the intracellular compartment as 
a defense mechanism. 
 The median of serum CRP level in this 
study was 6.03 mg/L with a wide range of 0.3 to 
339.29 mg/L. A total of 51.0% of subjects had 
elevated CRP levels above 5 mg/L. Increased levels 
of CRP may be associated with an increased risk of 
cancer, proportional to the severity of disease, and 
increased tumor size.15,16 Increased levels of CRP is 
also associated with poor prognosis of cancer.10  
 In this study, there was a statistically 
significant negative weak correlation between serum 
zinc level and serum CRP levels in head and neck 
cancer patients (r =-0.292, p =0.042). No literature 
mention the correlation between serum zinc levels 
and serum CRP levels in head and neck cancers yet, 
however there were reports of zinc levels with CRP 
levels correlation in lung cancer patients. Study by 
Sattar et al14 in lung cancer subjects had significant 
negative correlation between zinc and CRP 
concentration (r =-0.66, p <0.05). This is consistent 
with the theory that zinc has anti-inflammatory 
properties which can inhibit the formation of 
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proinflammatory cytokines and then decrease the 
CRP. Studies of cell cultures in less and enough zinc 
conditions found that zinc induces upregulation of 
A20 protein which is one of the inhibitors of NF-κB 
activation as a major transcription factor of 
inflammation.17 However, zinc deficiency condition 
may also induce the apoptosis and endothelial cell 
dysfunction due to increased concentrations of 
proinflammatory cytokines and oxidative stress.8 
In conclusion, we found negative correlation 
between serum zinc level and c-reactive protein 
level in head and neck subject, so it can be used as 
the basic data for further research development of 
the possibility of providing supplementation for 
head and neck cancer patients. 
 
Conflict of Interest 
 
Some of this study funds was supported by the 
Tulang Bawang district government.  
 
Open Access 
 
This article is distributed under the terms of the  
Creative Commons Attribution 4.0 International 
Licence(http://creativecommons.org/licenses/by/4.0
/), which permits unrestricted use, distribution, and 
reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the 
source, provide a link to the Creative Commons 
license, and indicate if changes were made. 
 
Acknowledgement 
 
We are indebted to the medical and nursing staff of 
the Oncology Clinic, Dharmais Cancer Hospital, 
Jakarta. 
 
References 
 
1 Everett EV. Head and Neck Cancer. In: 
Harrison’s Principles of Internal medicine. 18th 
edition. USA: The Mc-Graw Hill Companies; 
2012. [Google Scholar] 
2 Argiris A, Eng C. Epidemiology, Staging, and 
Sreening of Head and Neck Cancer. In: Head and 
Neck Cancer. USA: Kluwer Academic 
Publishers; 2004. [Google Scholar] 
3 Boyle P, Levin B, editor. World Cancer Report 
2008. International Agency for Research on 
Cancer. World Health Organization; 2008.  
4 Muliawati Y, Haroen H, Rotty LWA. Cancer 
anorexia - cachexia syndrome. Acta Medica 
Indones 2012;44:154. [Google Scholar] 
5 Prasad AS, Bao B, Beck FWJ, Sarkar FH. Zinc-
suppressed inflammatory cytokines by induction 
of A20-mediated inhibition of nuclear factor-κB. 
Nutrition 2011;27:816. [Google Scholar] 
6 Skipworth RJE, Stewart GD, Dejong CHC, 
Preston T, Fearon KCH. Pathophysiology of 
cancer cachexia: Much more than host–tumour 
interaction. Clin Nutr 2007;26:667. [Google 
Scholar] 
7 Allin KH, Nordestgaard BG. Elevated C-reactive 
protein in the diagnosis, prognosis, and cause of 
cancer. Crit Rev Clin Lab Sci 2011;48:155. 
[Google Scholar] 
8 Prasad AS, Beck FW, Snell DC, Kucuk O. Zinc 
in cancer prevention. Nutrition and cancer 2009 
Nov;61(6):879-87. [Google Scholar] 
9 Irene . Kadar seng serum pada pasien kanker 
kepala dan leher serta hubungannya dengan 
status radiasi (tesis. Jakarta: Universitas 
Indonesia; 2012. [Google Scholar] 
10 Garofalo JA, Erlandson E, Strong EW, Lesser M, 
Gerold F, Spiro R, et al. Serum zinc, serum 
copper, and the Cu/Zn ratio in patients with 
epidermoid cancers of the head and neck. J Surg 
Oncol 1980;15:381. [Google Scholar] 
11 Abdulla M, Biörklund A, Mathur A, Wallenius 
K. Zinc and copper levels in whole blood and 
plasma from patients with squamous cell 
carcinomas of head and neck. J Surg Oncol 
1979;12:107. [Google Scholar] 
12 Mahdavi R, Faramarzi E, Mohammad-Zadeh M, 
Ghaeammaghami J, Jabbari MV. Consequences 
of radiotherapy on nutritional status, dietary 
intake, serum zinc and copper levels in patients 
with gastrointestinal tract and head and neck 
cancer. Saudi Med J 2007;28:435. [Google 
Scholar] 
13 Foster M, Samman S. Zinc and regulation of 
inflammatory cytokines: implications for 
 World.Nutr.Journal | 14  
cardiometabolic disease. Nutrients 2012;4:676. 
[Google Scholar] 
14 Bao B, Ahmad A, Azmi AS, Wang Z, Banerjee 
S, Sarkar FH. The Protective Role of Zinc in 
Cancer: A Potential Chemopreventive Agent. In: 
Shankar S, Srivastava RK, editors. Nutrition, 
Diet and Cancer. Springer Netherlands; 2012. 
[Google Scholar] 
15 Permenkes Tentang Angka Kecukupan Gizi 
[Internet]. Gizinet. [cited 2015 Oct 24]. Available 
from: http://gizi.depkes.go.id/permenkes-
tentang-angka-kecukupan-gizi 
16 Westin T, Ahlbom E, Johansson E, Sandström B, 
Karlberg I, Edström S. Circulating levels of 
selenium and zinc in relation to nutritional status 
in patients with head and neck cancer. Arch 
Otolaryngol Head Neck Surg 1989;115:1079. 
[Google Scholar] 
17 Sattar N, Scott HR, McMillan DC, Talwar D, 
O’Reilly DS, Fell GS. Acute-phase reactants and 
plasma trace element concentrations in non-small 
cell lung cancer patients and controls. Nutr 
Cancer 1997;28:308. [Google Scholar] 
18 Siren PM. Siren MJ. Systemic zinc redistribution 
and dyshomeostasis in cancer cachexia. J 
Cachexia Sarcopenia Muscle 2010;1:23. [Google 
Scholar] 
19 Chen HH, Wang HM, Fan KH, Lin CY, Yen TC, 
Liao CT, Chen IH, Kang CJ, Huang SF. Pre-
treatment levels of C-reactive protein and 
squamous cell carcinoma antigen for predicting 
the aggressiveness of pharyngolaryngeal 
carcinoma. PloS one. 2013 Jan 31;8(1):e55327. 
20 Aref H, Refaat S. CRP evaluation in non-small 
cell lung cancer. Egypt J Chest Dis Tuberc 
2014;63:717. [Google Scholar] 
